Onucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugs. Int J Oncol 22: 87581. Elbashir, SM, Harborth, J, Lendeckel, W, ERβ Agonist Accession Yalcin, A, Weber, K and Tuschl, T (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 49498. Pecot, CV, Calin, GA, Coleman, RL, Lopez-Berestein, G and Sood, AK (2011). RNA interference in the clinic: challenges and future directions. Nat Rev Cancer 11: 597. DYRK2 Inhibitor manufacturer Petros, RA and DeSimone, JM (2010). Tactics inside the design and style of nanoparticles for therapeutic applications. Nat Rev Drug Discov 9: 61527. Filion MC, Phillips NC (1998) Key limitations inside the use of cationic liposomes for DNA delivery. Int J Pharm 162: 15970. Bertrand, JR, Pottier, M, Vekris, A, Opolon, P, Maksimenko, A and Malvy, C (2002). Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem Biophys Res Commun 296: 1000004. Klionsky, DJ and Emr, SD (2000). Autophagy as a regulated pathway of cellular degradation. Science 290: 1717721. Dalby, KN, Tekedereli, I, Lopez-Berestein, G and Ozpolat, B (2010). Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic approaches in cancer. Autophagy 6: 32229. Akar, U, Chaves-Reyez, A, Barria, M, Tari, A, Sanguino, A, Kondo, Y et al. (2008). Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells. Autophagy 4: 66979. Ozpolat, B, Akar, U, Mehta, K and Lopez-Berestein, G (2007). PKC delta and tissue transglutaminase are novel inhibitors of autophagy in pancreatic cancer cells. Autophagy 3: 48083. Shen, HM and Codogno, P (2011). Autophagic cell death: Loch Ness monster or endangered species Autophagy 7: 45765. Trisciuoglio, D, Gabellini, C, Desideri, M, Ziparo, E, Zupi, G and Del Bufalo, D (2010). Bcl2 regulates HIF-1alpha protein stabilization in hypoxic melanoma cells through the molecular chaperone HSP90. PLoS One particular five: e11772. Pattingre, S, Tassa, A, Qu, X, Garuti, R, Liang, XH, Mizushima, N et al. (2005). Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122: 92739. Oh, S, Xiaofei, E, Ni, D, Pirooz, SD, Lee, JY, Lee, D et al. (2011). Downregulation of autophagy by Bcl-2 promotes MCF7 breast cancer cell growth independent of its inhibition of apoptosis. Cell Death Differ 18: 45264. Akar, U, Ozpolat, B, Mehta, K, Lopez-Berestein, G, Zhang, D, Ueno, NT et al. (2010). Targeting p70S6K prevented lung metastasis in a breast cancer xenograft model. Mol Cancer Ther 9: 1180187. Anai, S, Goodison, S, Shiverick, K, Hirao, Y, Brown, BD and Rosser, CJ (2007). Knockdown of Bcl-2 by antisense oligodeoxynucleotides induces radiosensitization and inhibition of angiogenesis in human PC-3 prostate tumor xenografts. Mol Cancer Ther 6: 10111. Iervolino, A, Trisciuoglio, D, Ribatti, D, Candiloro, A, Biroccio, A, Zupi, G et al. (2002). Bcl2 overexpression in human melanoma cells increases angiogenesis via VEGF mRNA stabilization and HIF-1-mediated transcriptional activity. FASEB J 16: 1453455. Li, X and Fan, Z (2010). The epidermal development factor receptor antibody cetuximab induces autophagy in cancer cells by downregulating HIF-1alpha and Bcl-2 and activating the beclin 1/hVps34 complex. Cancer Res 70: 5942952. Ricca, A, Biroccio, A, Del Bufalo, D, Mackay, AR, Santoni, A and Cippitelli, M (2000). bcl-2 over-expression enhances NF-kappaB activity and induces mmp-9 transcription in human MCF7(ADR) breast-cancer cells. Int J.
